Dr. Jamison Jaffe

Dr. Jamison Jaffe
Jamison Jaffe, D.O. joins the staff at Penn Medicine in Princeton as an accomplished urologic surgeon specializing in complex robotic and minimally invasive surgery for benign and cancerous urologic conditions. Dr. Jaffe completed fellowship training in advanced laparoscopic and robotic urologic surgery at the prestigious L’Institut Mutualiste Montsouris in Paris, France where the laparoscopic prostatectomy was pioneered. He completed residency in general surgery and urologic surgery at the Albert Einstein Medical Center in Philadelphia. He was named chief resident and Urology Resident of the Year in his final year of training. Board certified by the American Board of Osteopathic Surgery, Dr. Jaffe is an extensively published researcher and experienced presenter on complex laparoscopic and robotic surgeries at national and international conferences. For multiple years, Dr. Jaffe has been recognized nationally as a “Top Doc” in U.S. News and World Report, “Top Doctor in Urologic Surgery” by Philadelphia Magazine and a regional “Top Doctor” by Castle Connolly. Dr. Jaffe has previously served as the Urology Chair at St. Mary Medical Center and the Director of Minimally Invasive and Robotic Urologic Surgery at Hahnemann University Hospital and Drexel University College of Medicine. Dr. Jaffe has extensive experience in the field of Urologic Oncology. His focus of expertise is in the diagnosis, evaluation and minimally invasive and robotic treatments of urologic cancers including prostate, bladder, kidney, ureter, adrenal, and testicle cancers. He is among the most experienced urologists in the region using robotic technology to perform complex surgical procedures to help patients preserve their quality of life and live longer with less long term side effects from treatment. Dr. Jaffe also has a strong passion in the minimally invasive treatment of kidney stone disease and benign prostatic hyperplasia (BPH). He offers all of the latest minimally invasive treatment available for these benign conditions. His minimally invasive surgeries offer patients the benefits of reduced pain, smaller sometimes no incisions, less blood loss, and quicker recovery times.

Languages Spoken:

English and translation services available upon request

Medical School:

Philadelphia College of Osteopathic Medicine


Albert Einstein Medical Center


Institute Mutualiste Montsouris - Minimally Invasive and Robotic Urologic Surgery


Pennsylvania State University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only